Edelman MJ - Search Results

1

Phase 1-2a multicenter dose-ranging study of canfosfamide in combination with carboplatin and paclitaxel as first-line therapy for patients with advanced non-small cell lung cancer.

Sequist LV, Fidias PM, Temel JS, Kolevska T, Rabin MS, Boccia RV, Burris HA, Belt RJ, Huberman MS, Melnyk O, Mills GM, Englund CW, Caldwell DC, Keck JG, Meng L, Jones M, Brown GL, Edelman MJ, Lynch TJ. Sequist LV, et al. Among authors: edelman mj. J Thorac Oncol. 2009 Nov;4(11):1389-96. doi: 10.1097/JTO.0b013e3181b6b84b. J Thorac Oncol. 2009. PMID: 19701107 Free article. Clinical Trial.

2

High-dose toremifene as a cisplatin modulator in metastatic non-small cell lung cancer: targeted plasma levels are achievable clinically.

Lara PN Jr, Gandara DR, Wurz GT, Lau D, Uhrich M, Turrell C, Raschko J, Edelman MJ, Synold T, Doroshow J, Muggia F, Perez EA, DeGregorio M. Lara PN Jr, et al. Among authors: edelman mj. Cancer Chemother Pharmacol. 1998;42(6):504-8. doi: 10.1007/s002800050852. Cancer Chemother Pharmacol. 1998. PMID: 9788578 Clinical Trial.

3

Gemcitabine and carboplatin in combination: an update of phase I and phase II studies in non-small cell lung cancer.

Langer CJ, Gandara DR, Calvert P, Edelman MJ, Ozols RF. Langer CJ, et al. Among authors: edelman mj. Semin Oncol. 1999 Feb;26(1 Suppl 4):12-8. Semin Oncol. 1999. PMID: 10201516 Review.

4

Emerging role of docetaxel (Taxotere) in advanced non-small cell lung cancer.

Gandara DR, Edelman MJ, Lau D. Gandara DR, et al. Among authors: edelman mj. Semin Oncol. 1999 Jun;26(3 Suppl 10):3-7. Semin Oncol. 1999. PMID: 10437743 Review.

5

Twice-weekly paclitaxel and weekly carboplatin with concurrent thoracic radiation followed by carboplatin/paclitaxel consolidation for stage III non-small-cell lung cancer: a California Cancer Consortium phase II trial.

Lau D, Leigh B, Gandara D, Edelman M, Morgan R, Israel V, Lara P, Wilder R, Ryu J, Doroshow J. Lau D, et al. J Clin Oncol. 2001 Jan 15;19(2):442-7. doi: 10.1200/JCO.2001.19.2.442. J Clin Oncol. 2001. PMID: 11208837 Clinical Trial.

6

Sequential combination chemotherapy in patients with advanced nonsmall cell lung carcinoma: carboplatin and gemcitabine followed by paclitaxel.

Edelman MJ, Gandara DR, Lau DH, Lara P, Lauder IJ, Tracy D. Edelman MJ, et al. Cancer. 2001 Jul 1;92(1):146-52. doi: 10.1002/1097-0142(20010701)92:1<146::aid-cncr1302>3.0.co;2-n. Cancer. 2001. PMID: 11443620 Clinical Trial.

7

Interactions of gemcitabine, carboplatin and paclitaxel in molecularly defined non-small-cell lung cancer cell lines.

Edelman MJ, Quam H, Mullins B. Edelman MJ, et al. Cancer Chemother Pharmacol. 2001 Aug;48(2):141-4. doi: 10.1007/s002800000273. Cancer Chemother Pharmacol. 2001. PMID: 11561780

8

Advanced non-small cell lung cancer.

Edelman MJ, Khanwani SL. Edelman MJ, et al. Curr Treat Options Oncol. 2001 Feb;2(1):51-62. doi: 10.1007/s11864-001-0016-6. Curr Treat Options Oncol. 2001. PMID: 12057140 Review.

9

Past, present, and future of gemcitabine and carboplatin regimens in advanced non-small cell lung cancer.

Edelman MJ. Edelman MJ. Lung Cancer. 2002 Nov;38 Suppl 2:S37-43. doi: 10.1016/s0169-5002(02)00356-2. Lung Cancer. 2002. PMID: 12431828 Review.

10

The management of the patient undergoing combined modality therapy for locally advanced non-small cell lung cancer.

Edelman MJ, Suntharalingam M, Krasna MJ. Edelman MJ, et al. Curr Treat Options Oncol. 2003 Feb;4(1):45-53. doi: 10.1007/s11864-003-0030-y. Curr Treat Options Oncol. 2003. PMID: 12525278 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

235 results

Search Page